Liquidia Technologies, Inc. (LQDA) Social Stream

Featured Post From StockTwits About LQDA

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend!

$LQDA
Market Price - $2.73
Average Hold - $2.96
Accumulate - Sub $2.50 (raised from Sub $2.30)
Price Target - $3.75
Estimated Time Hold - 2Q
Support - $2.75, $3
Floor - $2.28
Double Down Target - Sub $2
Option - N/A
Micro DD - Announced June 2nd that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for LIQ861 (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH). The FDA confirmed that the resubmission was a complete, class 2 response to the previous action letter issued on November 24, 2020. The FDA set a PDUFA goal date of November 7, 2021.